S1827

デオキシコール酸ナトリウム

• 別名: 3α,12α-ジヒドロキシ-5β-コラン酸 ナトリウム塩, 7-デオキシコール酸 ナトリウム塩, デスオキシコール酸 ナトリウム塩
• 実験式（ヒル表記法）: C₂₄H₃₉NaO₄
• CAS番号: 302-95-4
• 分子量: 414.55
• Beilstein: 3581950
• EC Number: 206-132-7
• MDL番号: MFCD00064139
• UNSPSCコード: 12161900
• NACRES: NA.21

特性

• 由来生物: animal
• 品質水準: 400
• アッセイ: ≥98% (HPLC)
• 形状: powder
• 分子量: micellar avg mol wt 1200-5000
• 凝集数: 3-12
• CMC: 2-6 mM (20-25°C)
• HLB: 16
• 適合性: suitable for manufacturing use
• SMILES記法: [Na+].[H][C@]12CC[C@@]3([H])[C@]4([H])CC[C@H]([C@H](C)CCC([O-])=O)[C@@]4(C)[C@@H](O)C[C@]3([H])[C@@]1(C)CC[C@@H](O)C2
• InChI: 1S/C24H40O4.Na/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3;/h14-21,25-26H,4-13H2,1-3H3,(H,27,28);/q;+1/p-1/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-;/m1./s1
• InChI Key: FHHPUSMSKHSNKW-SMOYURAASA-M

詳細

詳細

Our SAFC^® portfolio of high-quality raw materials for use in biopharmaceutical processing withstands strict quality control procedures plus the documentation and expertise to help our customers meet requirements as defined by the M-Clarity Program.

M-Clarity Program

Our comprehensive portfolio of upstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Trust us to deliver supply chain transparency and reliable sourcing around the globe, streamlining your product qualification with best-in-class regulatory support and service.

法的情報

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302
• 注意書き: P264 - P270 - P301 + P312 - P501
• 危険有害性の分類: Acute Tox. 4 Oral
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 1
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable